To identify early molecular changes in knee joints associated with osteoarthritis (OA) progression, which could lead to improved diagnostic and therapeutic strategies.
Key Findings:
Strong upregulation of collagen-derived peptides and post-translational modifications linked to matrix stiffening in subchondral bone beneath damaged cartilage, indicating early disease processes.
Bone remodeling indicators were found even beneath structurally intact cartilage, suggesting early disease signals that could inform diagnosis.
Bone-associated protein fragments identified in tissue were also detected in synovial fluid from OA patients, while cartilage markers were reduced, highlighting the potential for fluid-based biomarkers.
Interpretation:
Subchondral bone may serve as an early indicator of osteoarthritis progression, with potential for developing fluid-based tests to assess joint remodeling and improve patient management.
Limitations:
Study focused on end-stage OA patients, which may limit generalizability to earlier stages of the disease.
Further validation needed to establish clinical applicability of identified biomarkers across diverse patient demographics.
Conclusion:
Tracking bone-specific molecular changes could facilitate earlier identification of at-risk patients and improve monitoring of therapeutic responses, ultimately enhancing patient outcomes.
